News & Updates

Switch to brexpiprazole in schizophrenia conveys minimal risk of metabolic abnormalities

14 Jul 2021

In patients with schizophrenia, switching to brexpiprazole from aripiprazole or nonaripiprazole dopamine antagonists is tied to a low risk of metabolic abnormalities, hyperprolactinaemia, extrapyramidal symptoms, and QTc changes, as shown in a study.

Switch to brexpiprazole in schizophrenia conveys minimal risk of metabolic abnormalities

14 Jul 2021

Postpartum haemorrhage deals long-term psychological harms to women, partners

13 Jul 2021

The long-term risk of psychological adverse outcomes after postpartum haemorrhage (PPH) is high among women and their partners, a recent study has found.

Postpartum haemorrhage deals long-term psychological harms to women, partners

13 Jul 2021

COVID-19 patients with mood disorders at greater risk of death, morbidity

12 Jul 2021 by

A history of mood disorder among hospitalized COVID-19 patients may increase their risk of morbidity and mortality, a US study has found. This population is also at higher risk of need for postacute care.

COVID-19 patients with mood disorders at greater risk of death, morbidity

12 Jul 2021

RhIGF-1 use confers no added benefit vs oestradiol alone in anorexia nervosa

11 Jul 2021

Administration of recombinant human insulin-like growth factor-1 (rhIGF-1) for 12 months does not appear to provide additional benefit over transdermal oestrogen replacement alone in a cohort of young women with anorexia nervosa, a study has shown.

RhIGF-1 use confers no added benefit vs oestradiol alone in anorexia nervosa

11 Jul 2021

COVID-19 can lead to cognitive, behavioural issues

10 Jul 2021 by

Some COVID-19 patients experienced cognitive and behavioural problems within 2 months after discharge from hospital, with certain symptoms persisting to 10 months, reveals a longitudinal study presented at EAN 2021.

COVID-19 can lead to cognitive, behavioural issues

10 Jul 2021

Crocin as good as fluoxetine in mild-to-moderate obsessive-compulsive disorder

10 Jul 2021

In the treatment of patients with mild-to-moderate obsessive-compulsive disorder, crocin appears to be as effective as fluoxetine, with the advantage of fewer adverse effects, according to a study.

Crocin as good as fluoxetine in mild-to-moderate obsessive-compulsive disorder

10 Jul 2021

Metabolic risk calculator predicts cardiometabolic risk in young adults with psychosis

09 Jul 2021 by

Experts in the UK have recently developed an age-appropriate algorithm for predicting the risk of incident metabolic syndrome, a precursor of cardiometabolic morbidity and mortality, in young adults with psychosis.

Metabolic risk calculator predicts cardiometabolic risk in young adults with psychosis

09 Jul 2021

Antiseizure pill offers hope for people with alcohol use disorder

08 Jul 2021 by

The antiseizure medication topiramate appears to reduce heavy drinking in individuals with alcohol use disorder by attenuating alcohol cue-elicited brain activation and craving, as shown in a recent study.

Antiseizure pill offers hope for people with alcohol use disorder

08 Jul 2021

Does clozapine increase susceptibility to COVID-19?

07 Jul 2021 by

The antipsychotic clozapine appears to contribute to increased risk of COVID-19 infection, a study has shown.

Does clozapine increase susceptibility to COVID-19?

07 Jul 2021

Zuranolone improves depressive symptoms in postpartum depression

07 Jul 2021 by

Results of a recent study demonstrated the effectiveness and safety of zuranolone in improving core symptoms of depression in women with postpartum depression (PPD).

Zuranolone improves depressive symptoms in postpartum depression

07 Jul 2021

News & Updates

Filter by Specialty:

Specialty:

Switch to brexpiprazole in schizophrenia conveys minimal risk of metabolic abnormalities

Switch to brexpiprazole in schizophrenia conveys minimal risk of metabolic abnormalities

Postpartum haemorrhage deals long-term psychological harms to women, partners

Postpartum haemorrhage deals long-term psychological harms to women, partners

COVID-19 patients with mood disorders at greater risk of death, morbidity

COVID-19 patients with mood disorders at greater risk of death, morbidity

RhIGF-1 use confers no added benefit vs oestradiol alone in anorexia nervosa

RhIGF-1 use confers no added benefit vs oestradiol alone in anorexia nervosa

COVID-19 can lead to cognitive, behavioural issues

COVID-19 can lead to cognitive, behavioural issues

Crocin as good as fluoxetine in mild-to-moderate obsessive-compulsive disorder

Crocin as good as fluoxetine in mild-to-moderate obsessive-compulsive disorder

Metabolic risk calculator predicts cardiometabolic risk in young adults with psychosis

Metabolic risk calculator predicts cardiometabolic risk in young adults with psychosis

Antiseizure pill offers hope for people with alcohol use disorder

Antiseizure pill offers hope for people with alcohol use disorder

Does clozapine increase susceptibility to COVID-19?

Does clozapine increase susceptibility to COVID-19?

Zuranolone improves depressive symptoms in postpartum depression

Zuranolone improves depressive symptoms in postpartum depression